Standout Papers

Evinacumab for Homozygous Familial Hypercholesterolemia 2020 2026 2022 2024446
  1. Evinacumab for Homozygous Familial Hypercholesterolemia (2020)
    Frederick J. Raal, Robert S. Rosenson et al. New England Journal of Medicine

Immediate Impact

6 from Science/Nature 45 standout
Sub-graph 1 of 14

Citing Papers

Refining the impact of genetic evidence on clinical success
2024 StandoutNature
GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy
2023 Standout
1 intermediate paper

Works of Paolo Rubba being referenced

Evinacumab for Homozygous Familial Hypercholesterolemia
2020 Standout
Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia
2017

Author Peers

Author Last Decade Papers Cites
Paolo Rubba 1966 1667 1060 149 4.5k
John Goudevenos 2980 1599 698 192 6.1k
Lance D. Dworkin 1867 1649 1005 170 8.1k
Viviane Nicaud 1934 1268 1666 112 5.7k
Eric de Groot 2192 2409 1390 97 5.7k
Genovefa Kolovou 1731 1339 1376 247 4.4k
George Thanassoulis 2458 2177 1106 145 5.1k
Anna Maria Gori 4062 2193 682 238 7.5k
Per Tornvall 3252 1779 932 186 6.6k
Tsuyoshi Watanabe 1278 914 1235 221 6.4k
Jane Armitage 1149 2563 1158 90 5.6k

All Works

Loading papers...

Rankless by CCL
2026